|
|
Other links at Articles > HIV/AIDS |
| 1. |
Update on the Development of HIV Entry Inhibitors
|
|
|
With the approval of raltegravir, oral agents targeting all three constitutive viral enzymes, reverse transcriptase, protease and integrase, are now represented in FDA-approved therapies.
Future HIV Therapy
|
| 2. |
Preventing Brain Damage In HIV Infection
|
|
|
This review focuses on current research regarding cerebral spinal fluid biomarkers and effects of highly active antiretroviral treatment on HIV-1 CNS disease.
Future Neurology
|
| 4. |
New HIV Drug Stalls Infection in Trial
|
|
|
A new kind of experimental HIV medicine can halt one of the earliest stages of HIV infection and may lead in future to a novel class of drugs to fight other dangerous viruses, German scientists said on Wednesday. Reuters Health Information
|
|
|
